Home

Investor Relations

Company Profile

Corporate Governance

Management Team

Board of Directors

Committee Composition

Stock Information

Analysts Coverage

Email Alerts

Press Room

Annual Report and Proxy

SEC Filings

Investor FAQs

Shareholder Briefcase

 

 

Committee Composition

Display all Bios

Committee Chair = Chair Committee Member = Member
  Audit Nominating and Governance Compensation
Luke Evnin Ph.D   Member of Nominating and Governance Committee Member of Compensation Committee
Catherine Friedman Committee Chair for Audit Committee    

Catherine Friedman has served as one of our directors since May 2007. Ms. Friedman currently is an independent financial consultant serving private and public companies in the lifesciences. Prior to that, Ms. Friedman held numerous positions over a 23 year investment banking career with Morgan Stanley. Ms. Friedman held the position of Managing Director at Morgan Stanley from 1997 to 2006 and Head of West Coast Healthcare and Co-Head of the Biotechnology Practice at Morgan Stanley from 1993 to 2006. Ms. Friedman joined the board of XenoPort Inc., a publicly-held biopharmaceutical company, in September 2007 and also serves on its audit committee.

Carl Goldfischer M.D.   Committee Chair for Nominating and Governance Committee  
Bobby I. Griffin   Observer Rights Member of Compensation Committee
Donald C. Harrison M.D. Member of Audit Committee    
Paul H. Klingenstein Member of Audit Committee Member of Nominating and Governance Committee  
Nicholas L. Teti Jr.      
Jon T. Tremmel     Committee Chair for Compensation Committee


 

 

Home | What is VBLOC® Therapy? | Why VBLOC® Therapy?
Bariatric Weight Loss Surgery | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised May 2009.